In the NEJM Phase 2 trial, participants assigned to an initial dose of 4 mg experienced significantly more adverse events than those who started at 2 mg, even when both groups ultimately reached the same target dose
Research has demonstrated that bortezomib-resistant cells in multiple myeloma redirect glucose toward the pentose phosphate pathway and serine synthesis pathway, enhancing their antioxidant capabilities
Featured Ingredients: Lysine, Arginine, Proline, Vitamin C, B Vitamins, Magnesium, Zinc Let your skin steal the spotlight with our Brightening IV Therapy, featuring glutathione the bodys master antioxidant plus a radiant blend of vitamins that detoxify, hydrate, and illuminate from the inside out
It helps regenerate vitamins C and E, extending their effectiveness in protecting your skin